您的位置: 首页 > 农业专利 > 详情页

NOUVEAU DERIVE DE PYRAZOLE EN TANT QU'INHIBITEUR D'ALK5 ET SES UTILISATIONS
专利权人:
LTD.;HANMI PHARMACEUTICAL CO.
发明人:
LEE, KYUNG IK,JUNG, YOUNG HEE,SONG, JI YOUNG,JUN, SEUNG AH
申请号:
CA3029175
公开号:
CA3029175A1
申请日:
2017.06.30
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present invention relates to a novel substituted pyrazole derivative, having the effect of inhibiting the serine/threonine kinase activity, targeting the receptor ALK5 of TGF-ß. A pharmaceutical composition containing a compound of the present invention as an active ingredient can be usefully used in the treatment and/or prevention of cancer, an autoimmune disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an infectious disease, a pulmonary disease, a cardiovascular disease or a metabolic disease or other diseases associated with a decrease in TGF family signaling activity.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充